J&J, Distributors Set To Unveil Opioid Deals Worth $26B

Law360 (July 20, 2021, 1:06 AM EDT) -- Negotiators are expected to announce this week that they've hammered out the fine print on global opioid settlements worth $26 billion — including roughly $2.5 billion for attorney fees and costs — with Johnson & Johnson and the nation's largest drug distributors, a source close to the talks said Monday.

Johnson & Johnson and the nation's largest drug distributors have hammered out the details of opioid settlements worth $26 billion, a source close to the matter said Monday. (Photo by Mario Tama/Getty Images) If approved by enough states and local governments, the resolutions would end the majority of opioid crisis cases...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!